| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Poseida Therapeutics, Inc. | Director | Common Stock | 0 | $0 | $9.60 | 08 Jan 2025 | Direct |
| Poseida Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 0 | 08 Jan 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| PSTX | Poseida Therapeutics, Inc. | 08 Jan 2025 | 5 | $0 | 4 | Director | 08 Jan 2025, 14:17 |
| PSTX | Poseida Therapeutics, Inc. | 17 Jun 2024 | 2 | $0 | 4 | Director | 18 Jun 2024, 16:15 |
| PSTX | Poseida Therapeutics, Inc. | 15 Jun 2023 | 2 | $0 | 4 | Director | 16 Jun 2023, 16:07 |
| PSTX | Poseida Therapeutics, Inc. | 16 Jun 2022 | 2 | $0 | 4 | Director | 16 Jun 2022, 20:57 |
| PSTX | Poseida Therapeutics, Inc. | 25 Aug 2021 | 1 | $0 | 4 | Director | 27 Aug 2021, 17:08 |